C
Charles A. Powell
Researcher at Icahn School of Medicine at Mount Sinai
Publications - 156
Citations - 16700
Charles A. Powell is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Lung cancer & Adenocarcinoma. The author has an hindex of 45, co-authored 137 publications receiving 12790 citations. Previous affiliations of Charles A. Powell include Columbia University Medical Center & Columbia University.
Papers
More filters
Journal ArticleDOI
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
William D. Travis,Elisabeth Brambilla,Masayuki Noguchi,Andrew G. Nicholson,Kim R. Geisinger,Yasushi Yatabe,David G. Beer,Charles A. Powell,Gregory J. Riely,Paul Van Schil,Kavita Garg,John H. M. Austin,Hisao Asamura,Valerie W. Rusch,Fred R. Hirsch,Giorgio V. Scagliotti,Tetsuya Mitsudomi,Rudolf M. Huber,Yuichi Ishikawa,James R. Jett,Montserrat Sanchez-Cespedes,Jean-Paul Sculier,Takashi Takahashi,Masahiro Tsuboi,Johan Vansteenkiste,Ignacio I. Wistuba,Pan-Chyr Yang,Denise R. Aberle,Christian Brambilla,Douglas B. Flieder,Wilbur A. Franklin,Adi F. Gazdar,Michael K. Gould,Philip S. Hasleton,Douglas W. Henderson,Bruce E. Johnson,David A Johnson,Keith M. Kerr,Keiko Kuriyama,Jin Soo Lee,Vincent A. Miller,Iver Petersen,Victor L. Roggli,Rafael Rosell,Nagahiro Saijo,Erik Thunnissen,M. Tsao,David Yankelewitz +47 more
TL;DR: This new adenocarcinoma classification is needed to provide uniform terminology and diagnostic criteria, especially for bronchioloalveolar carcinoma (BAC), the overall approach to small nonresection cancer specimens, and for multidisciplinary strategic management of tissue for molecular and immunohistochemical studies.
Journal ArticleDOI
The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification
William D. Travis,Elisabeth Brambilla,Andrew G. Nicholson,Yasushi Yatabe,John H.M. Austin,Mary Beth Beasley,Lucian R. Chirieac,Sanja Dacic,Edwina Duhig,Douglas B. Flieder,Kim R. Geisinger,Fred R. Hirsch,Yuichi Ishikawa,Keith M. Kerr,Masayuki Noguchi,Giuseppe Pelosi,Charles A. Powell,Ming-Sound Tsao,Ignacio I. Wistuba +18 more
TL;DR: The 2015 World Health Organization (WHO) Classification of Tumors of the Lung, Pleura, Thymus and Heart has just been published with numerous important changes from the 2004 WHO classification.
Journal ArticleDOI
Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017
Heber MacMahon,David P. Naidich,Jin Mo Goo,Kyung Soo Lee,Ann N. Leung,John R. Mayo,Atul C. Mehta,Yoshiharu Ohno,Charles A. Powell,Mathias Prokop,Geoffrey D. Rubin,Cornelia M. Schaefer-Prokop,William D. Travis,Paul Van Schil,Alexander A. Bankier +14 more
TL;DR: These guidelines represent the consensus of the Fleischner Society, and as such, they incorporate the opinions of a multidisciplinary international group of thoracic radiologists, pulmonologists, surgeons, pathologists, and other specialists.
Journal ArticleDOI
Global Epidemiology of Lung Cancer
TL;DR: The evidence on lung cancer epidemiology, including data of international scope with comparisons of economically, socially, and biologically different patient groups is reviewed, including a discussion on the epidemiologic characteristics of special groups including women and nonsmokers.
Journal ArticleDOI
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary.
William D. Travis,Elisabeth Brambilla,Masayuki Noguchi,Andrew G. Nicholson,Kim R. Geisinger,Yasushi Yatabe,Charles A. Powell,David G. Beer,G. J. Riely,Kavita Garg,John H. M. Austin,Valerie W. Rusch,Fred R. Hirsch,James R. Jett,Pan-Chyr Yang,Michael Gould +15 more
TL;DR: Non-small cell lung carcinomas (NSCLC), in patients with advanced stage disease, are to be classified into more specific types, such as adenocarcinoma or squamous cell carcinoma, whenever possible.